CYTOKINETICS INC — Director's Dealing 2024

Mar 19, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2024-03-14

Reporting Person: Callos Andrew (EVP, Chief Commercial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-03-14	Common Stock	A	16941	—	Acquired	63887	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-03-14	Non-Qualified Stock Option (Right to Buy)	$63.75	A	18346	Acquired	2034-03-14	Common Stock (18346)	Direct
2024-03-14	Incentive Stock Option (Right to Buy)	$63.75	A	1224	Acquired	2034-03-14	Common Stock (1224)	Direct

Footnotes

F1: Award comprised of Restricted Stock Units that will vest over 3-years, with 40% vesting on the 1-year anniversary of the date of grant, an additional 40% vesting on the 2-year anniversary of the date of grant, and the remaining 20% vesting on the 3-year anniversary of the date of grant.

F2: This option shall vest and become exercisable in equal monthly installments over 4 years commencing on April 15, 2024, with the final installment vesting on March 14, 2028.